Literature DB >> 20038223

Treatment of aggressive systemic mastocytosis with daclizumab.

Alfonso Quintás-Cardama, Hesham M Amin, Hagop Kantarjian, Srdan Verstovsek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20038223     DOI: 10.3109/10428190903470869

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis.

Authors:  Alfonso Quintás-Cardama; Nitin Jain; Srdan Verstovsek
Journal:  Cancer       Date:  2011-06-20       Impact factor: 6.860

2.  International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.

Authors:  Jason Gotlib; Animesh Pardanani; Cem Akin; Andreas Reiter; Tracy George; Olivier Hermine; Hanneke Kluin-Nelemans; Karin Hartmann; Wolfgang R Sperr; Knut Brockow; Lawrence B Schwartz; Alberto Orfao; Daniel J Deangelo; Michel Arock; Karl Sotlar; Hans-Peter Horny; Dean D Metcalfe; Luis Escribano; Srdan Verstovsek; Ayalew Tefferi; Peter Valent
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

3.  Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis.

Authors:  Noelia Dasilva-Freire; Andrea Mayado; Cristina Teodosio; María Jara-Acevedo; Iván Álvarez-Twose; Almudena Matito; Laura Sánchez-Muñoz; Carolina Caldas; Ana Henriques; Javier I Muñoz-González; Andrés C García-Montero; J Ignacio Sánchez-Gallego; Luis Escribano; Alberto Orfao
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.